A Proof-of-Concept Study on Utilizing a Novel Non-invasive Sensor for Detection of Thin Biofilm in Simulated Water Pipes

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Sachin Davis ◽  
Marcia R. Silva
Metabolism ◽  
2019 ◽  
Vol 101 ◽  
pp. 154005 ◽  
Author(s):  
Nikolaos Perakakis ◽  
Stergios A. Polyzos ◽  
Alireza Yazdani ◽  
Aleix Sala-Vila ◽  
Jannis Kountouras ◽  
...  

PLoS ONE ◽  
2020 ◽  
Vol 15 (7) ◽  
pp. e0235933 ◽  
Author(s):  
Jenna H. Sobey ◽  
Srijaya K. Reddy ◽  
Kyle M. Hocking ◽  
Monica E. Polcz ◽  
Christy M. Guth ◽  
...  

2020 ◽  
Vol 37 (23) ◽  
pp. 2569-2579
Author(s):  
Jonas B. Fischer ◽  
Ameer Ghouse ◽  
Susanna Tagliabue ◽  
Federica Maruccia ◽  
Anna Rey-Perez ◽  
...  

Gut ◽  
2017 ◽  
Vol 67 (3) ◽  
pp. 593-594 ◽  
Author(s):  
Julian A Luetkens ◽  
Sabine Klein ◽  
Frank Traeber ◽  
Frederic C Schmeel ◽  
Alois M Sprinkart ◽  
...  

2021 ◽  
Vol 9 (1) ◽  
pp. e002027
Author(s):  
Brinnae Bent ◽  
Peter J Cho ◽  
April Wittmann ◽  
Connie Thacker ◽  
Srikanth Muppidi ◽  
...  

IntroductionDiabetes prevalence continues to grow and there remains a significant diagnostic gap in one-third of the US population that has pre-diabetes. Innovative, practical strategies to improve monitoring of glycemic health are desperately needed. In this proof-of-concept study, we explore the relationship between non-invasive wearables and glycemic metrics and demonstrate the feasibility of using non-invasive wearables to estimate glycemic metrics, including hemoglobin A1c (HbA1c) and glucose variability metrics.Research design and methodsWe recorded over 25 000 measurements from a continuous glucose monitor (CGM) with simultaneous wrist-worn wearable (skin temperature, electrodermal activity, heart rate, and accelerometry sensors) data over 8–10 days in 16 participants with normal glycemic state and pre-diabetes (HbA1c 5.2–6.4). We used data from the wearable to develop machine learning models to predict HbA1c recorded on day 0 and glucose variability calculated from the CGM. We tested the accuracy of the HbA1c model on a retrospective, external validation cohort of 10 additional participants and compared results against CGM-based HbA1c estimation models.ResultsA total of 250 days of data from 26 participants were collected. Out of the 27 models of glucose variability metrics that we developed using non-invasive wearables, 11 of the models achieved high accuracy (<10% mean average per cent error, MAPE). Our HbA1c estimation model using non-invasive wearables data achieved MAPE of 5.1% on an external validation cohort. The ranking of wearable sensor’s importance in estimating HbA1c was skin temperature (33%), electrodermal activity (28%), accelerometry (25%), and heart rate (14%).ConclusionsThis study demonstrates the feasibility of using non-invasive wearables to estimate glucose variability metrics and HbA1c for glycemic monitoring and investigates the relationship between non-invasive wearables and the glycemic metrics of glucose variability and HbA1c. The methods used in this study can be used to inform future studies confirming the results of this proof-of-concept study.


2021 ◽  
Vol 3 (4) ◽  
pp. e262-e269
Author(s):  
Sara Marsal ◽  
Héctor Corominas ◽  
Juan José de Agustín ◽  
Carolina Pérez-García ◽  
María López-Lasanta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document